Final tick is ASX approval and Absolutely if they have some decent revenue starting to show, it might be another couple of months but I have a feeling we are very close now to relisting. Like others I want to get a better understanding of the revised business plan but overall I am really excited about the potential and especially Canntab in Asia which will provide massive revenue/dividends in coming years imo
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held